Rene Maltais
Quebec, QC G1V4G2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Aminosteroid RM-581 Induces G0/G1 Arrest and Endoplasmic Reticulum Stress-Mediated Apoptosis in Human Acute and Chronic Leukemia Cell Lines.
Journal: Cancers
Published: February 21, 2026
Development of a Multigram Synthetic Route to RM-581, an Orally Active Aminosteroid Derivative Against Several Types of Cancers.
Journal: Molecules (Basel, Switzerland)
Published: May 09, 2025
Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology
Published: April 05, 2024
Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities.
Journal: Antioxidants (Basel, Switzerland)
Published: February 20, 2024
A protectin DX (PDX) analog with in vitro activity against influenza A(H1N1) viruses.
Journal: Journal of medical virology
Published: November 09, 2023
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments.
Journal: Journal of clinical medicine
Published: May 15, 2023
An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models.
Journal: Cancers
Published: April 01, 2023
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone.
Journal: Molecules (Basel, Switzerland)
Published: December 01, 2022
Chemical synthesis of fluorinated and iodinated 17β-HSD3 inhibitors and evaluation for imaging prostate cancer tumors and tissue biodistribution.
Journal: Bioorganic chemistry
Published: June 20, 2022
An irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis.
Journal: The Journal of steroid biochemistry and molecular biology
Published: March 09, 2022
Last Updated: 09/26/2026